American Association for Cancer Research
Browse

Figure 3 from Evaluating the Radiation Sensitivity Index and 12-Chemokine Gene Expression Signature for Clinical Use in a CLIA Laboratory

Download (653.96 kB)
figure
posted on 2025-03-03, 08:40 authored by Anders E. Berglund, John Puskas, Sean J. Yoder, Andrew T. Smith, Douglas C. Marchion, Dahui Qin, James J. Mulé, Javier F. Torres-Roca, Steven A. Eschrich

A, Impact of the amount of input RNA on GES scores. Three samples were profiled using different amounts of input RNA (100, 25, 10, 5, and 2.5 ng). Lower 12CK GES scores were observed at 2.5 ng, suggesting a lower limit on input RNA. RSI demonstrated more variability overall but did not seem to have a systematic difference at 2.5 ng. B, Impact of macrodissection on signature scores. Three samples were profiled across three different sample conditions: T, N and non-macrodissected tissue (PM). As expected, normal tissue can result in large changes to the signature score, which can be seen in PM as well. For instance, the 12CK GES score for normal tissue from sample 1 is much higher; however, there is elevated signal in the PM sample as well. By contrast, the differences in sample 3 (N, T, and PM) are small.

History

ARTICLE ABSTRACT

The RSI and 12CK GES are two GESs that predict tumor radiation sensitivity or the presence of tertiary lymphoid structures in tumors, respectively. These GESs were assessed within the CLIA process for future clinical use. We established proficiency, reproducibility, and reliability characteristics for both signatures in a controlled setting, indicating these GESs are suitable for validation within future clinical trials.